No Data
No Data
No Data
No Data
No Data
VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald
VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald
Dow JonesMar 27 10:05 ET
VolitionRX Is Maintained at Buy by EF Hutton
VolitionRX Is Maintained at Buy by EF Hutton
Dow JonesMar 27 09:51 ET
EF Hutton Maintains Buy on VolitionRX, Maintains $4.5 Price Target
EF Hutton analyst Tim Moore maintains VolitionRX with a Buy and maintains $4.5 price target.
Analyst UpgradesMar 27 09:43 ET
VolitionRX Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 500.56% EF Hutton $4.5 → $4.5 Maintains Buy 01/02/2024 500.56% EF Hutton $4.5 → $4.5 Reiterates
BenzingaMar 27 09:37 ET
Benchmark Co. Sticks to Its Hold Rating for VolitionRX (VNRX)
TipRanksMar 27 08:26 ET
Earnings Call Summary | VolitionRX(VNRX.US) Q4 2023 Earnings Conference
The following is a summary of the VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript:Financial Performance:VolitionRx recorded revenue of $775,000 for the full year 2023, a significantly highe
moomoo AIMar 26 13:12 ET · Conference Call
gentle Bat_4825 : Yes
Ehsan Moradi : Brf
70182552 : @OldNormanBates三月五号出财报,不知如何
OldNormanBatesOP 70182552: Will be showing up in the NEWS Section of Moomoo to tell you about it.
OldNormanBatesOP 70182552: Check out the company website.
70182552 OldNormanBatesOP: @OldNormanBates明白了,谢谢你,但原是个好的成绩,股票就会涨
OldNormanBatesOP 70182552: Not Always.. But Typically you are going to see Positive movement before the ER Earnings Report,if Earnings is GOOD, because most Analysts will have a good idea what is going to happen..On the other hand, typically you are going to see a Drop in Price After the ER, If Earnings, because they have made a mistake of what is it is.Yes
No Data
No Data